Robert van Nostrand
Chairman chez YIELD10 BIOSCIENCE, INC.
Fortune : 699 533 $ au 31/03/2024
Profil
Robert L.
van Nostrand is currently the Independent Chairman at Yield10 Bioscience, Inc. He is also the Treasurer & Director at New York Biotechnology Association, Inc. Additionally, he serves as the Director at Brany LLC, Lead Independent Director at Intra-Cellular Therapies, Inc., Director at ITI, Inc. (New York), Director at Sellas Life Sciences Group Ltd., Independent Director at SELLAS Life Sciences Group, Inc., Director at LikeMinds, Inc. (Massachusetts), and Member at Association of Biofinance Officers.
In his former positions, Mr. van Nostrand served as the Chairman at Farmingdale College Foundation.
He was also an Independent Director at Achillion Pharmaceuticals, Inc. from 2007 to 2020.
He held the position of Director at Achillion Pharmaceuticals, Inc., Director at Apex Bioventures Acquisition Corp., Independent Director at Enumeral Biomedical Holdings, Inc., Director at Apex Bioventures LLC, Director at Enumeral Biomedical Corp., Director at SELLAS Life Sciences Group, Inc., Chief Compliance Officer & Senior Vice President at OSI Pharmaceuticals, Inc. from 2005 to 2007, Chief Financial Officer & Executive Vice President at Applied Genetics, Inc. Dermatics from 2007 to 2008, Chief Financial Officer & Executive Vice President at Aureon Biosciences, Inc. in 2010, and Manager at Touche Ross & Co. He also served as the Chief Financial Officer & Executive Vice President at Aureon Laboratories, Inc.
Mr. van Nostrand obtained his undergraduate degree from Long Island University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2024 | 9 690 ( 0,01% ) | 670 548 $ | 31/03/2024 | |
YIELD10 BIOSCIENCE, INC.
0,41% | 28/03/2024 | 48 635 ( 0,41% ) | 18 481 $ | 31/03/2024 |
| 22/01/2024 | 10 400 ( 0,02% ) | 10 504 $ | 31/03/2024 |
Postes actifs de Robert van Nostrand
| Sociétés | Poste | Début |
|---|---|---|
| INTRA-CELLULAR THERAPIES, INC. | Director/Board Member | 08/01/2014 |
| YIELD10 BIOSCIENCE, INC. | Chairman | 08/11/2011 |
| SELLAS LIFE SCIENCES GROUP, INC. | Director/Board Member | 29/12/2017 |
LikeMinds, Inc. (Massachusetts)
 LikeMinds, Inc. (Massachusetts) Personnel ServicesCommercial Services LikeMinds, Inc. intends to make brain imaging part of the standard suite of healthcare diagnostic tests and technologies. The company was founded in 2018 and is headquartered in Boston, MA. | Director/Board Member | - |
Sellas Life Sciences Group Ltd.
 Sellas Life Sciences Group Ltd. Pharmaceuticals: MajorHealth Technology Sellas Life Sciences Group Ltd. manufactures pharmaceutical products. It focuses on innovative products to treat cancer and central nervous system diseases. The firm’s product candidate, licensed from Memorial Sloan-Kettering Cancer Center is a late-stage innovative WT1-targeting synthetic heteroclitic epitope immunotherapeutic in development for hematological malignancies and solid tumors characterized by an overexpression of the WT1 (Wilms Tumor Protein) antigen. The company was founded by Angelos M. Stergiou in 2012 and is headquartered in Zug, Switzerland. | Director/Board Member | 29/12/2017 |
| ITI, Inc. (New York) | Director/Board Member | 01/01/2014 |
Brany LLC
 Brany LLC Miscellaneous Commercial ServicesCommercial Services Brany LLC is a private company that has been providing support to sponsors, institutions, and investigators since 1998. The company is based in Lake Success, NY. The company offers IRB and clinical trial solutions that can fill in gaps or enhance existing processes. | Director/Board Member | 01/01/2011 |
| Association of Biofinance Officers | Corporate Officer/Principal | - |
New York Biotechnology Association, Inc.
 New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | Director/Board Member | 20/07/2012 |
Anciens postes connus de Robert van Nostrand
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formation de Robert van Nostrand
| Long Island University | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| YIELD10 BIOSCIENCE, INC. | Process Industries |
| INTRA-CELLULAR THERAPIES, INC. | Health Technology |
| SELLAS LIFE SCIENCES GROUP, INC. | Health Technology |
| Entreprise privées | 18 |
|---|---|
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
Applied Genetics, Inc. Dermatics
 Applied Genetics, Inc. Dermatics Pharmaceuticals: MajorHealth Technology Applied Genetics, Inc. Dermatics develops and markets pharmaceutical drugs, skincare ingredients and prestige products. It develops array of cosmetic ingredients to use in skin care products. The company has focused on ingredients for skin protection from environmental damage. The firm also has a topical pharmaceutical product in clinical testing called Dimericine for cancer-prone skin. Applied Genetics was founded by Daniel B Yarosh and Karen Yarosh in May 1985 and is headquartered in Freeport, NY. | Health Technology |
Aureon Biosciences, Inc.
 Aureon Biosciences, Inc. BiotechnologyHealth Technology Aureon Biosciences, Inc. designs and develops prognostic tests. The company’s prognostic tests include Prostate Px, which assists physicians as they counsel patients on the range of possible treatment options, as well as the patient’s probability of disease recurrence, disease progression and Post-Op Px, a prognostic test to provide patients and their physicians with information about treatment options. The company was founded by Robert H. Singer, Charles M. Cohen, Jonathan Edelson, Olivier Saidi and Carlos Cordón-Cardó in 2001 and is headquartered in Yonkers, NY. | Health Technology |
Apex Bioventures Acquisition Corp.
 Apex Bioventures Acquisition Corp. Financial ConglomeratesFinance The Company is a blank check company. It is formed to acquire one or more domestic or foreign operating business in the healthcare industry through merger, capital stock exchange, asset acquisition or other similar business combination. The Company is in the development stage. On February 5, 2008, the Company entered into an Agreement and Plan of Merger with Dynogen Pharmaceuticals, Inc and its acting representatives. | Finance |
Enumeral Biomedical Holdings, Inc.
 Enumeral Biomedical Holdings, Inc. BiotechnologyHealth Technology Enumeral Biomedical Holdings, Inc. is a biopharmaceutical company, which engages in the business of discovering and developing novel antibody immunotherapies for the treatment of cancer and other diseases. It also focuses on the development of a pipeline of next generation monoclonal antibody drugs targeting established and novel immuno-modulatory receptors. The company was founded by Barry C. Buckland, John J. Rydzewski, and Arthur H. Tinkelenberg on December 11, 2009 and is headquartered in Arlington, MA. | Health Technology |
| Touche Ross & Co. | Commercial Services |
New York Biotechnology Association, Inc.
New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | Commercial Services |
| Association of Biofinance Officers | |
| Apex Bioventures LLC | |
Enumeral Biomedical Corp.
 Enumeral Biomedical Corp. Miscellaneous Commercial ServicesCommercial Services Enumeral Biomedical Corp. develops monoclonal antibodies for diagnosis and treatment of infectious, autoimmune and inflammatory diseases. Its proprietary micro engraving technology creates spatially-registered, high-density bio-chip microarrays of the secreted products of single human cells derived from patient samples to provide rapid and simultaneous analysis of antibody affinity and specificity as well as cytokine profiles and T-cell functionality. The company was founded in 2009 by J. Christopher Love, Emanuele Ostuni and Barry Buckland and is headquartered in New York, NY. | Commercial Services |
Brany LLC
Brany LLC Miscellaneous Commercial ServicesCommercial Services Brany LLC is a private company that has been providing support to sponsors, institutions, and investigators since 1998. The company is based in Lake Success, NY. The company offers IRB and clinical trial solutions that can fill in gaps or enhance existing processes. | Commercial Services |
| ITI, Inc. (New York) | |
| Farmingdale College Foundation | |
SELLAS Life Sciences Group, Inc. /Old/
 SELLAS Life Sciences Group, Inc. /Old/ BiotechnologyHealth Technology SELLAS Life Sciences Group, Inc. /Old/ is based in New York, NY. SELLAS Life Sciences Group, Inc. is a clinical-stage biopharmaceutical company. | Health Technology |
LikeMinds, Inc. (Massachusetts)
LikeMinds, Inc. (Massachusetts) Personnel ServicesCommercial Services LikeMinds, Inc. intends to make brain imaging part of the standard suite of healthcare diagnostic tests and technologies. The company was founded in 2018 and is headquartered in Boston, MA. | Commercial Services |
| Aureon Laboratories, Inc. | |
Sellas Life Sciences Group Ltd.
Sellas Life Sciences Group Ltd. Pharmaceuticals: MajorHealth Technology Sellas Life Sciences Group Ltd. manufactures pharmaceutical products. It focuses on innovative products to treat cancer and central nervous system diseases. The firm’s product candidate, licensed from Memorial Sloan-Kettering Cancer Center is a late-stage innovative WT1-targeting synthetic heteroclitic epitope immunotherapeutic in development for hematological malignancies and solid tumors characterized by an overexpression of the WT1 (Wilms Tumor Protein) antigen. The company was founded by Angelos M. Stergiou in 2012 and is headquartered in Zug, Switzerland. | Health Technology |
